Raymond James analyst Bobby Griffin raised his price target for Purple Innovation (PRPL) to $13 from $11 and reaffirmed his Outperform rating after spending some time with senior management at the ICR investor conference. Griffin tells investors in a research note that he left the meetings feeling confident that the positive fundamental drivers of Purple's business, as well as the sizable future revenue and EBITDA growth opportunity are still both well intact and says he is encouraged around the early commentary on how Purple is performing on Mattress Firm's floor alongside Tempur-Pedic (TPX).